The instruction for medical use
of Tsinepar medicine an asset
the Trade name
Tsinepar an asset
the International unlicensed name
Is not present
the Dosage form
Gel for external use
Structure
100 g of gel contain
active agents: diclofenac diethyl amine of 1.16 g (it is equivalent to diclofenac of sodium of 1 g), linseed oil of 3 g, methyl salicylate of 10 g, menthol of 5 g
excipients: benzyl alcohol, carbomer 974, akrizol K-140, isopropyl alcohol, propylene glycol, ethanolamine, dinatrium edetat, butyl hydroxytoluene, water purified.
Description
Gel of white or almost white color.
Pharmacotherapeutic group
Other drugs for topical treatment of diseases of the musculoskeletal system.
The ATX M02AX code
the Pharmacological
Pharmacokinetics At properties local putting drug adsorption is 6%. 99.7% of diclofenac contact proteins of serum and generally (99.4%) albumine. Diclofenac collects in skin, acting as a source of the slowed-down release of substance in the subject fabrics. From there diclofenac is distributed and remains mainly in the deep inflamed fabrics where reaches concentration by 20 times exceeding
concentration in plasma. Diclofenac partially is exposed to metabolism by a direct glyukuronidation in various phenolic derivatives. Two of phenolic derivatives of a bioaktivna, but in considerable smaller degree. The general clearance of diclofenac in plasma is 263 ml/min. Elimination half-life of a diklofeak and its metabolites makes 1-2 hours. One of metabolites 3-hydroxy-4-metoksidiklofenak possesses longer elimination half-life. Diclofenac and its metabolites are removed mainly by kidneys.
A pharmacodynamics
Active component - diclofenac the non-steroidal anti-inflammatory drug having analgeziruyushchy and anti-inflammatory properties. The main mechanism of effect of diclofenac consists in suppression of biosynthesis of prostaglandins namely, not selectively oppressing a cyclooxygynase 1 and 2 types, breaks metabolism of arachidonic acid.
Gel is used for elimination of a pain syndrome and reduction of puffiness connected with inflammatory process and the analgeziruyushchy action caused by oppression of synthesis of prostagladin reduces hypostasis, pain, hyperaemia on the site of application of drug.
Methyl salicylate – derivatives of salicylic acid, not selectively inhibits cyclooxygenase, reduces synthesis of PG. Normalizes hyperpermeability of capillaries, improves microcirculation processes, reduces hypostasis and infiltration of the inflamed fabrics. At local applique quickly gets into deep skin layers, is absorbed, hydrolyzed and turns into anion of salicylic acid. The main component of linseed oil is alpha linolenic acid (ethyl ether of unsaturated fatty acid) which also has anti-inflammatory effect, reduces dryness and irritation of skin.
Menthol at rubbing in in skin causes irritation of sensitive nerve terminations at the expense of what renders the local distracting and moderate anesthetizing action.
Indications
- posttraumatic inflammation of ligaments and sinews, muscles and joints,
(stretching, an overstrain and bruises)
- inflammatory and degenerative diseases of soft tissues (a tendovaginitis, a syndrome a shoulder - a brush, a bursitis, a periarthritis)
- the pain syndrome and puffiness connected with diseases of muscles and
joints (pseudorheumatism, an osteoarthrosis, sciaticas, a lumbago, a sciatica)
the Route of administration and doses
Outwardly. 2-4 g of drug (4-8 cm of the gel which is forced out from a tuba), depending on the area of the painful center, apply 3-4 times a day on affected areas and carefully pound.
The course of treatment should not exceed 10 days.
Side effects
Allergic reactions - seldom rash, an erythema, an itching, urticaria.
At prolonged use, system side effects - generalized skin rash, a bronchospasm, a Quincke's disease, a photosensitization are possible.
At emergence of the specified symptoms it is necessary to stop drug use.
Contraindications
- hypersensitivity to diclofenac, aspirin and other
non-steroidal anti-inflammatory drugs
- bronchial asthma
- disturbance of integrity of integuments
- pregnancy, the lactation period
- children's age up to 6 years
Medicinal interactions
interaction Cases Tsinepar of ACTIVE gel with other drugs are not described.
The special
instructions Apply only as external means.
Tsinepar ACTIVE gel should be applied only to the uninjured skin.
Not to apply drug on the damaged surface of skin, open wounds, eyes and mucous membranes.
Influence on ability to driving of motor transport and to control of mechanisms
does not influence
Overdose
the Form of release and packing
On 20 g is not revealed, 50 g of gel place in the plastic laminated tubas with the screwing-up plastic cover. The tuba together with the instruction for medical use in the state and Russian languages is put in a pack from cardboard.
To Store storage conditions in the dry, protected from light place at a temperature not higher than 25 wasps.
Not to freeze!
To store out of children's reach!
3 years
not to use a period of storage after expiry date!
Prescription status
Without prescription
of Distribyyutor Kyyuramaks Ltd, England
Marion Biotek Pvt.Ltd. Producer
B-49, Sector-67, Noiade, India
Owner of the registration certificate
Marion Biotek Pvt.Ltd., India
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods) of Spectramax LLP, Republic of Kazakhstan, Almaty, Seyfullin Ave. 458-460/95, office 312 Number of phone/fax +7 (727) 344-94-37 (8) E-mail address of vikaskaushik@quramax.com
of Tsinepar medicine an asset
the Trade name
Tsinepar an asset
the International unlicensed name
Is not present
the Dosage form
Gel for external use
Structure
100 g of gel contain
active agents: diclofenac diethyl amine of 1.16 g (it is equivalent to diclofenac of sodium of 1 g), linseed oil of 3 g, methyl salicylate of 10 g, menthol of 5 g
excipients: benzyl alcohol, carbomer 974, akrizol K-140, isopropyl alcohol, propylene glycol, ethanolamine, dinatrium edetat, butyl hydroxytoluene, water purified.
Description
Gel of white or almost white color.
Pharmacotherapeutic group
Other drugs for topical treatment of diseases of the musculoskeletal system.
The ATX M02AX code
the Pharmacological
Pharmacokinetics At properties local putting drug adsorption is 6%. 99.7% of diclofenac contact proteins of serum and generally (99.4%) albumine. Diclofenac collects in skin, acting as a source of the slowed-down release of substance in the subject fabrics. From there diclofenac is distributed and remains mainly in the deep inflamed fabrics where reaches concentration by 20 times exceeding
concentration in plasma. Diclofenac partially is exposed to metabolism by a direct glyukuronidation in various phenolic derivatives. Two of phenolic derivatives of a bioaktivna, but in considerable smaller degree. The general clearance of diclofenac in plasma is 263 ml/min. Elimination half-life of a diklofeak and its metabolites makes 1-2 hours. One of metabolites 3-hydroxy-4-metoksidiklofenak possesses longer elimination half-life. Diclofenac and its metabolites are removed mainly by kidneys.
A pharmacodynamics
Active component - diclofenac the non-steroidal anti-inflammatory drug having analgeziruyushchy and anti-inflammatory properties. The main mechanism of effect of diclofenac consists in suppression of biosynthesis of prostaglandins namely, not selectively oppressing a cyclooxygynase 1 and 2 types, breaks metabolism of arachidonic acid.
Gel is used for elimination of a pain syndrome and reduction of puffiness connected with inflammatory process and the analgeziruyushchy action caused by oppression of synthesis of prostagladin reduces hypostasis, pain, hyperaemia on the site of application of drug.
Methyl salicylate – derivatives of salicylic acid, not selectively inhibits cyclooxygenase, reduces synthesis of PG. Normalizes hyperpermeability of capillaries, improves microcirculation processes, reduces hypostasis and infiltration of the inflamed fabrics. At local applique quickly gets into deep skin layers, is absorbed, hydrolyzed and turns into anion of salicylic acid. The main component of linseed oil is alpha linolenic acid (ethyl ether of unsaturated fatty acid) which also has anti-inflammatory effect, reduces dryness and irritation of skin.
Menthol at rubbing in in skin causes irritation of sensitive nerve terminations at the expense of what renders the local distracting and moderate anesthetizing action.
Indications
- posttraumatic inflammation of ligaments and sinews, muscles and joints,
(stretching, an overstrain and bruises)
- inflammatory and degenerative diseases of soft tissues (a tendovaginitis, a syndrome a shoulder - a brush, a bursitis, a periarthritis)
- the pain syndrome and puffiness connected with diseases of muscles and
joints (pseudorheumatism, an osteoarthrosis, sciaticas, a lumbago, a sciatica)
the Route of administration and doses
Outwardly. 2-4 g of drug (4-8 cm of the gel which is forced out from a tuba), depending on the area of the painful center, apply 3-4 times a day on affected areas and carefully pound.
The course of treatment should not exceed 10 days.
Side effects
Allergic reactions - seldom rash, an erythema, an itching, urticaria.
At prolonged use, system side effects - generalized skin rash, a bronchospasm, a Quincke's disease, a photosensitization are possible.
At emergence of the specified symptoms it is necessary to stop drug use.
Contraindications
- hypersensitivity to diclofenac, aspirin and other
non-steroidal anti-inflammatory drugs
- bronchial asthma
- disturbance of integrity of integuments
- pregnancy, the lactation period
- children's age up to 6 years
Medicinal interactions
interaction Cases Tsinepar of ACTIVE gel with other drugs are not described.
The special
instructions Apply only as external means.
Tsinepar ACTIVE gel should be applied only to the uninjured skin.
Not to apply drug on the damaged surface of skin, open wounds, eyes and mucous membranes.
Influence on ability to driving of motor transport and to control of mechanisms
does not influence
Overdose
the Form of release and packing
On 20 g is not revealed, 50 g of gel place in the plastic laminated tubas with the screwing-up plastic cover. The tuba together with the instruction for medical use in the state and Russian languages is put in a pack from cardboard.
To Store storage conditions in the dry, protected from light place at a temperature not higher than 25 wasps.
Not to freeze!
To store out of children's reach!
3 years
not to use a period of storage after expiry date!
Prescription status
Without prescription
of Distribyyutor Kyyuramaks Ltd, England
Marion Biotek Pvt.Ltd. Producer
B-49, Sector-67, Noiade, India
Owner of the registration certificate
Marion Biotek Pvt.Ltd., India
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods) of Spectramax LLP, Republic of Kazakhstan, Almaty, Seyfullin Ave. 458-460/95, office 312 Number of phone/fax +7 (727) 344-94-37 (8) E-mail address of vikaskaushik@quramax.com
Related Products
Laboratorios Menarini S.A. (Spain)
Nimesil® granules for oral suspension 100 mg/2 g, 30 sachets
$32.70